Safety, Tolerability and Performance of the NucleoCapture Extracorporeal Therapeutic Apheresis Device in the Reduction of Circulating cfDNA/NETs in Subjects With Pancreatitis

NCT06566638 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER_GOV

Sponsor class

Conditions

Acute Pancreatitis
Organ Failure, Multiple

Interventions

DEVICE: NucleoCapture device

Sponsor

Liverpool University Hospitals NHS Foundation Trust

Collaborators

[object Object]